TNF inhibitors in patients with a history of cancer – controversial evidence

TNF inhibitors in patients with a history of cancer – controversial evidence

0 Comments

medicine

Wednesday, 19 June 2024

Vienna – Since the introduction of TNF inhibitors (TNFi) to treat inflammatory diseases such as rheumatoid arthritis (RA), doctors have been concerned that they increase the risk of cancer. The disease-modifying drugs (DMARDs) have now been used for almost 25 years. Was the concern justified? Experts discussed this at the European Rheumatology Congress in Vienna (EULAR 2024)….

#TNF #inhibitors #patients #history #cancer #controversial #evidence

Leave a Reply

Related Posts